rs2072797

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015374.3(SUN2):​c.2011G>A​(p.Gly671Ser) variant causes a missense change. The variant allele was found at a frequency of 0.11 in 1,613,644 control chromosomes in the GnomAD database, including 10,681 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G671G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.090 ( 831 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9850 hom. )

Consequence

SUN2
NM_015374.3 missense

Scores

3
4
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 5.80

Publications

37 publications found
Variant links:
Genes affected
SUN2 (HGNC:14210): (Sad1 and UNC84 domain containing 2) SUN1 (MIM 607723) and SUN2 are inner nuclear membrane (INM) proteins that play a major role in nuclear-cytoplasmic connection by formation of a 'bridge' across the nuclear envelope, known as the LINC complex, via interaction with the conserved luminal KASH domain of nesprins (e.g., SYNE1; MIM 608441) located in the outer nuclear membrane (ONM). The LINC complex provides a direct connection between the nuclear lamina and the cytoskeleton, which contributes to nuclear positioning and cellular rigidity (summary by Haque et al., 2010 [PubMed 19933576]).[supplied by OMIM, Nov 2010]
GTPBP1 (HGNC:4669): (GTP binding protein 1) This gene is upregulated by interferon-gamma and encodes a protein that is a member of the AGP11/GTPBP1 family of GTP-binding proteins. A structurally similar protein has been found in mouse, where disruption of the gene for that protein had no observable phenotype. [provided by RefSeq, Jul 2008]
GTPBP1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1
    Inheritance: AR Classification: MODERATE Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016545057).
BP6
Variant 22-38738202-C-T is Benign according to our data. Variant chr22-38738202-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SUN2NM_015374.3 linkc.2011G>A p.Gly671Ser missense_variant Exon 17 of 18 ENST00000689035.1 NP_056189.1 Q9UH99-1A0A024R1P7B4E2A6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SUN2ENST00000689035.1 linkc.2011G>A p.Gly671Ser missense_variant Exon 17 of 18 NM_015374.3 ENSP00000508608.1 Q9UH99-1

Frequencies

GnomAD3 genomes
AF:
0.0900
AC:
13689
AN:
152030
Hom.:
834
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0208
Gnomad AMI
AF:
0.233
Gnomad AMR
AF:
0.0678
Gnomad ASJ
AF:
0.0919
Gnomad EAS
AF:
0.165
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.161
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.0906
GnomAD2 exomes
AF:
0.109
AC:
27287
AN:
251384
AF XY:
0.112
show subpopulations
Gnomad AFR exome
AF:
0.0173
Gnomad AMR exome
AF:
0.0458
Gnomad ASJ exome
AF:
0.0866
Gnomad EAS exome
AF:
0.181
Gnomad FIN exome
AF:
0.165
Gnomad NFE exome
AF:
0.116
Gnomad OTH exome
AF:
0.111
GnomAD4 exome
AF:
0.112
AC:
164218
AN:
1461496
Hom.:
9850
Cov.:
32
AF XY:
0.113
AC XY:
81885
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.0171
AC:
572
AN:
33478
American (AMR)
AF:
0.0495
AC:
2215
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0925
AC:
2418
AN:
26132
East Asian (EAS)
AF:
0.160
AC:
6335
AN:
39694
South Asian (SAS)
AF:
0.121
AC:
10403
AN:
86248
European-Finnish (FIN)
AF:
0.160
AC:
8522
AN:
53252
Middle Eastern (MID)
AF:
0.101
AC:
585
AN:
5768
European-Non Finnish (NFE)
AF:
0.114
AC:
126735
AN:
1111814
Other (OTH)
AF:
0.107
AC:
6433
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
7984
15969
23953
31938
39922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4612
9224
13836
18448
23060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0899
AC:
13680
AN:
152148
Hom.:
831
Cov.:
32
AF XY:
0.0925
AC XY:
6881
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0207
AC:
861
AN:
41518
American (AMR)
AF:
0.0677
AC:
1035
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0919
AC:
319
AN:
3470
East Asian (EAS)
AF:
0.165
AC:
852
AN:
5168
South Asian (SAS)
AF:
0.126
AC:
609
AN:
4822
European-Finnish (FIN)
AF:
0.161
AC:
1699
AN:
10576
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7858
AN:
67990
Other (OTH)
AF:
0.0897
AC:
189
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
650
1300
1950
2600
3250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
2632
Bravo
AF:
0.0823
TwinsUK
AF:
0.115
AC:
427
ALSPAC
AF:
0.124
AC:
477
ESP6500AA
AF:
0.0213
AC:
94
ESP6500EA
AF:
0.114
AC:
977
ExAC
AF:
0.109
AC:
13251
Asia WGS
AF:
0.137
AC:
479
AN:
3478
EpiCase
AF:
0.113
EpiControl
AF:
0.115

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17827388) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Emery-Dreifuss muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.30
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.38
T;.;T;.
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.76
.;T;T;T
MetaRNN
Benign
0.0017
T;T;T;T
MetaSVM
Benign
-1.2
T
MutationAssessor
Benign
1.9
L;.;L;.
PhyloP100
5.8
PrimateAI
Benign
0.42
T
PROVEAN
Pathogenic
-5.5
D;D;D;D
REVEL
Benign
0.13
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Uncertain
0.021
D;D;D;D
Polyphen
0.35
B;.;B;.
Vest4
0.28
MPC
0.69
ClinPred
0.046
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.86
gMVP
0.74
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072797; hg19: chr22-39134207; COSMIC: COSV53283367; COSMIC: COSV53283367; API